A market assessment of neuromodulation non-invasive devices in migraine treatment Thailand

Migraine is a neurological condition that leads to intense, one-sided head pain, often coupled with nausea, vomiting, and heightened sensitivity to light and sound. This disorder affects about 13.5% of people worldwide, with a higher incidence in women (18.4%) compared to men (9.4%). Beyond the physical pain, migraines notably disrupt work or school productivity, family interactions, daily burden, and healthcare expenses. Current treatments often face challenges regarding their effectiveness and tolerance. Nonetheless, digital therapeutic neuromodulation techniques have shown potential in effectively treating migraines. This research purpose is to assess the market, identify challenges, and outline the factors for commercialization of Non-invasive neuromodulation device, Concept A in Thailand. The research methodology combines desk research and primary research to gather and analyze relevant data. The findings offer valuable insights for medical device manufacturers aiming to enter the Thai market, particularly for migraine treatment devices.